Lineage Cell Therapeutics Inc

ASE:LCTX   3:59:51 PM EDT
1.26
+0.04 (+3.28%)
Earnings Announcements

Lineage Cell Therapeutics Reports Q1 2022 Results

Published: 05/12/2022 21:10 GMT
Lineage Cell Therapeutics Inc (LCTX) - Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update.
Qtrly Loss per Share $0.04.
Q1 Earnings per Share View $-0.03 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $3.7 Million
Adjusted EPS is expected to be -$0.03

Next Quarter Revenue Guidance is expected to be $3.68 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.